Clinical Trial Update: Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Origin [NA]

View source ↗

Summary

A clinical trial studying isotopic distribution of intraperitoneal chemotherapy for peritoneal carcinomatosis of ovarian origin has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Centre Jean Perrin | Conditions: Ovarian Cancer | NA | Status: WITHDRAWN